Cargando…

Intravenous ferric derisomaltose versus oral iron for persistent iron deficient pregnant women: a randomised controlled trial

PURPOSE: To compare the efficacy of intravenous (IV) iron (ferric derisomaltose) with oral iron (ferrous fumarate) in women 14–21 weeks pregnant with persistent iron deficiency (ferritin < 30 µg/L). METHODS: In a single-centre, open-label, randomised controlled trial at a Danish hospital, women w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hansen, Rebecka, Sommer, Veronika Markova, Pinborg, Anja, Krebs, Lone, Thomsen, Lars Lykke, Moos, Torben, Holm, Charlotte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Maternal-Fetal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435604/ https://www.ncbi.nlm.nih.gov/pubmed/36107229 http://dx.doi.org/10.1007/s00404-022-06768-x

Ejemplares similares

Intravenous iron isomaltoside versus oral iron supplementation for treatment of iron deficiency in pregnancy: protocol for a randomised, comparative, open-label trial
por: Markova, Veronika, et al.
Publicado: (2020)

Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
por: Froessler, Bernd, et al.
Publicado: (2018)

Incidence of postpartum depression after treatment of postpartum anaemia with intravenous ferric carboxymaltose, intravenous ferric derisomaltose or oral ferrous sulphate: A randomized clinical trial
por: Bombač Tavčar, Lea, et al.
Publicado: (2023)

Intravenous ferric derisomaltose for the treatment of iron deficiency anemia
por: Auerbach, Michael, et al.
Publicado: (2021)

Impairment of the Developing Human Brain in Iron Deficiency: Correlations to Findings in Experimental Animals and Prospects for Early Intervention Therapy
por: Markova, Veronika, et al.
Publicado: (2019)

High-Dose Intravenous Iron with Either Ferric Carboxymaltose or Ferric Derisomaltose: A Benefit-Risk Assessment
por: Boots, Johannes M. M., et al.
Publicado: (2022)

Intravenous ferric carboxymaltose and ferric derisomaltose alter the intestinal microbiome in female iron-deficient anemic mice
por: Rieg, Timo, et al.
Publicado: (2023)

Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON‐IDA/NEPHRO trials
por: Wolf, Myles, et al.
Publicado: (2020)

Iron homeostasis in heart transplant recipients randomized to ferric derisomaltose or placebo
por: Brautaset Englund, Kristine V., et al.
Publicado: (2022)

Efficacy and safety of ferric derisomaltose (FDI) compared with iron sucrose (IS) in patients with iron deficiency anemia after bariatric surgery
por: Auerbach, Michael, et al.
Publicado: (2022)

Association between routine cell salvage use for lower segment caesarean section and post-operative iron infusion and anemia
por: Fox, Tom P., et al.
Publicado: (2023)

Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study
por: Kawabata, Hiroshi, et al.
Publicado: (2022)

Laboratory characteristics of pregnant compared to non-pregnant women infected with SARS-CoV-2
por: Mohr-Sasson, Aya, et al.
Publicado: (2020)

Hypophosphatemia after high-dose iron repletion with ferric carboxymaltose and ferric derisomaltose—the randomized controlled HOMe aFers study
por: Emrich, I. E., et al.
Publicado: (2020)

Intravenous ferric derisomaltose for iron-deficiency anemia associated with gastrointestinal diseases: a single-arm, randomized, uncontrolled, open-label study
por: Kawabata, Hiroshi, et al.
Publicado: (2022)

Correction to: Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study
por: Kawabata, Hiroshi, et al.
Publicado: (2022)

Assessment of dietary intake and mineral status in pregnant women
por: Kocyłowski, Rafał, et al.
Publicado: (2018)

Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trial
por: Zoller, Heinz, et al.
Publicado: (2023)

Anxiety, depression and concerns of pregnant women during the COVID-19 pandemic
por: Akgor, Utku, et al.
Publicado: (2021)

Pregnant and breastfeeding women’s attitudes and fears regarding the COVID-19 vaccination
por: Schaal, Nora K., et al.
Publicado: (2021)

Oral versus patient-controlled intravenous administration of oxycodone for pain relief after cesarean section
por: Mäkelä, Katja, et al.
Publicado: (2019)

Retrospective study of pregnant women placed under expectant management for persistent hemorrhage
por: Aoki, Shigeru, et al.
Publicado: (2013)

Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial
por: Bhandari, Sunil, et al.
Publicado: (2020)

A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status
por: Bhandari, S., et al.
Publicado: (2021)

A 6 month extension trial evaluating safety and efficacy of ferric derisomaltose in patients with iron deficiency anemia: The FERWON‐EXT trial
por: Achebe, Maureen M., et al.
Publicado: (2020)

Vaginal delivery in SARS-CoV-2-infected pregnant women in Israel: a multicenter prospective analysis
por: Rottenstreich, Amihai, et al.
Publicado: (2020)

Poor maternal–neonatal outcomes in pregnant patients with confirmed SARS-Cov-2 infection: analysis of 145 cases
por: Di Guardo, Federica, et al.
Publicado: (2021)

An Economic Analysis of Ferric Derisomaltose versus Ferric Carboxymaltose in the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease in Norway, Sweden, and Finland
por: Pollock, Richard F, et al.
Publicado: (2021)

A Systematic Review, Meta-Analysis, and Indirect Comparison of Blindly Adjudicated Cardiovascular Event Incidence with Ferric Derisomaltose, Ferric Carboxymaltose, and Iron Sucrose
por: Pollock, Richard F., et al.
Publicado: (2022)

Non-invasive risk-assessment and bleeding prophylaxis with IVIG in pregnant women with a history of fetal and neonatal alloimmune thrombocytopenia: management to minimize adverse events
por: Wienzek-Lischka, Sandra, et al.
Publicado: (2020)

Does wearing double surgical masks during the COVID-19 pandemic reduce maternal oxygen saturation in term pregnant women?: A prospective study
por: Isikalan, Mehmet Murat, et al.
Publicado: (2021)

Comparison of clinical features and perinatal outcomes between pre-variant and post-variant periods in pregnant women with SARS-CoV-2: analysis of 1935 cases
por: Sahin, Dilek, et al.
Publicado: (2022)

Telephonic intervention to combat non-adherence to oral iron-folic acid supplementation in pregnancy: A randomized controlled trial
por: Sharma, Sakshi, et al.
Publicado: (2023)

Real-world experience of intravenous ferric derisomaltose evaluated through safety and efficacy reporting in the UK
por: Sinclair, Rhona C. F., et al.
Publicado: (2022)

Placenta accreta spectrum disorders—experience of management in a German tertiary perinatal centre
por: Bluth, Anja, et al.
Publicado: (2020)

Iron deficiency and iron treatment in the fetal developing brain – a pilot study introducing an experimental rat model
por: Moos, Torben, et al.
Publicado: (2018)

Intravenous ferric derisomaltose in iron-deficient patients undergoing transcatheter aortic valve implantation due to severe aortic stenosis: study protocol of the randomised controlled IIISAS trial
por: Bardan, Sara, et al.
Publicado: (2022)

Maternal socioeconomic and lifestyle factors and life dissatisfaction associated with a small for gestational age infant. The Survey of Neonates in Pomerania (SNiP)
por: Pierdant, Guillermo, et al.
Publicado: (2022)

Comparing forces on the fetal neck in breech delivery in lithotomy versus all-fours position: a simulation model
por: Fard, Delnaz, et al.
Publicado: (2022)

Ferric derisomaltose and Outcomes in the Recovery of Gynecologic oncology: ERAS (Enhanced Recovery After Surgery) (FORGE) – a protocol for a pilot randomised double-blinded parallel-group placebo-controlled study of the feasibility and efficacy of intravenous ferric derisomaltose to correct preoperative iron-deficiency anaemia in patients undergoing gynaecological oncology surgery
por: Bisch, Steven P, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mh79ovk5ugjh3n8pq414t48e3g